Nicole Vitullo's Net Worth

$225 Thousand

Who is Nicole Vitullo?

Nicole Vitullo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Volcano Corp, Bionano Genomics, Inc., Orexigen Therapeutics, Inc., ZOGENIX, INC., CoLucid Pharmaceuticals, Inc., TANDEM DIABETES CARE INC, MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., NUVASIVE INC, Alliqua BioMedical, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, aTYR PHARMA INC, ALIMERA SCIENCES INC, OTONOMY, INC., Neothetics, Inc., NOVACEA INC, Durata Therapeutics, Inc., Ocera Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Achaogen Inc, Regado Biosciences Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, Somaxon Pharmaceuticals, Inc., Northstar Neuroscience, Inc., and ONYX PHARMACEUTICALS INC.

SEC CIK

Nicole Vitullo's CIK is 0001196863

Past Insider Trading and Trends

2017 was Nicole Vitullo's most active year for acquiring shares with 6 total transactions. Nicole Vitullo's most active month to acquire stocks was the month of April. 2020 was Nicole Vitullo's most active year for disposing of shares, totalling 10 transactions. Nicole Vitullo's most active month to dispose stocks was the month of December. 2010 saw Nicole Vitullo paying a total of $75,500.00 for 100,000 shares, this is the most they've acquired in one year. In 2020 Nicole Vitullo cashed out on 308,431 shares for a total of $229,515.30, their largest year based on trade value.